Autopsy report · NCT00992108

Efficacy of Botulinum Toxin Versus Lidocaine in Treating Masticatory Myofascial Face Pain Using Ultrasound and EMG Guided Techniques

“Lack of eligible patients willing and able to participate”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year before it stopped.
• 17 participants enrolled.
• Results were posted on the registry 6 years 2 months after it ended.

Vital statistics

Status

Terminated

Phase

Phase 4

Sponsor

University of California, Los Angeles

Sponsor type

University, hospital or other

Conditions

Face Pain

Interventions

lidocaine; chemodenervation

Participants

17

Sites

1

Countries

United States

Trials that died the same way

• Serial Evaluation of Drug-Eluting Stents Using OCT (STRUT-OCT)
  “Lack of eligible patients” (93% match in meaning)
• Endothelial Protection in Convalescent COVID-19 Patients
  “Lack of the eligible patients” (92% match in meaning)
• Non-alcoholic Fatty Liver Disease (NAFLD) in HIV: The Role of Nutritional Interventions
  “Not enough eligible patients available” (87% match in meaning)
• TRAUMA HELP: Healing and Analgesia With Propranolol
  “Lack of eligible patient recruits/feasibility considerations.” (85% match in meaning)
• African American Families Fighting Parental Cancer Together
  “Insufficient patients meet eligibility requirements.” (84% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.